Home › Essential Thrombocythemia › Michigan › Ann Arbor
Essential Thrombocythemia clinical trials in Ann Arbor, MI
3 studies for Essential Thrombocythemia are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- University of Michigan Rogel Cancer Center Adult Bone Marrow Transplant Clinic, Ann Arbor
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
RecruitingPhase 3
- University of Michigan ( Site 6000), Ann Arbor
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
RecruitingPhase 1
- Site US06, Ann Arbor
Essential Thrombocythemia trials in other cities
- New York City, NY8 studies
- Durham, NC7 studies
- Nashville, TN5 studies
- Salt Lake City, UT5 studies
- Boston, MA5 studies
- Baltimore, MD5 studies
- Mountain View, CA4 studies
- Irvine, CA4 studies
- Columbus, OH4 studies
- Miami, FL4 studies
- Chicago, IL4 studies
- Houston, TX4 studies
Other studies in Ann Arbor
- Prostate Cancer26 studies
- Cancer (all types)25 studies
- Breast Cancer25 studies
- Lung Cancer23 studies
- Non-Small Cell Lung Cancer23 studies
- Colorectal Cancer22 studies
- Heart Failure21 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease15 studies
- Pancreatic Cancer14 studies
- Multiple Myeloma13 studies
- Atrial Fibrillation12 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.